ZIOPHARM Oncology, Inc. (ZIOP) Posts Narrower than Expected Q4 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- US stock futures rise as investors assess Democrats' midterm sweep
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts ZIOP Hot Sheet
Price: $0.87 --0%
Financial Fact:
General and administrative: 3.54M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
General and administrative: 3.54M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) reported Q4 EPS of ($0.24), $0.05 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $170 thousand.
For earnings history and earnings-related data on ZIOPHARM Oncology, Inc. (ZIOP) click here.
For earnings history and earnings-related data on ZIOPHARM Oncology, Inc. (ZIOP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FTC Solar, Inc (FTCI) Tops Q3 EPS by 15c; Offers Guidance
- MarineMax (HZO) Tops Q4 EPS by 4c
- Materion Corp. (MTRN) Tops Q3 EPS by 2c, Misses on Revenue; Offers FY26 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
